to determine the efficacy and safety of Kolofort in the treatment of patients with irritable bowel syndrome (IBS).
SUBJECTS AND METHODS
52 patients (16 men and 36 women) aged 26 to 59 years were examined over 4 months to rule out organic disease. The diagnosis of IBS was established on the basis of the Rome III diagnostic criteria (2006). Seven… (More)